Ondine Biomedical Inc. (AIM: OBI)

Ondine Biomedical Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2010
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2010
Cash & Equivalents	1.22	2.98	13.13	30.37	0.63	0.88
Cash & Short-Term Investments	1.22	2.98	13.13	30.37	0.63	0.88
Cash Growth	-72.56%	-77.29%	-56.78%	4750.64%	-28.58%	-16.98%
Accounts Receivable	0.23	0.32	0.13	0.16	0.54	0.26
Other Receivables	0.01	0	0.05	0.09	0.01	-
Receivables	0.24	0.33	0.18	0.25	0.54	0.26
Inventory	1.29	1.07	1.29	1.06	0.4	0.23
Prepaid Expenses	0.33	0.22	0.38	1.83	0.17	0.28
Restricted Cash	0.15	0.16	0.15	-	-	-
Total Current Assets	3.22	4.75	15.13	33.5	1.75	1.64
Property, Plant & Equipment	0.77	0.95	1.4	0.6	0.67	0.48
Other Intangible Assets	-	-	-	-	0.17	0.41
Other Long-Term Assets	0.04	0.04	0.04	0.04	0.05	-
Total Assets	4.03	5.73	16.57	34.14	2.64	2.53
Accounts Payable	1.88	1.36	0.39	1.2	0.77	1.4
Accrued Expenses	1.56	1.75	3.16	2.08	0.64	-
Short-Term Debt	-	-	-	-	26.99	0.5
Current Portion of Long-Term Debt	-	-	-	-	7.16	-
Current Portion of Leases	0.35	0.38	0.36	0.15	0.23	-
Current Income Taxes Payable	-	-	-	-	-	0
Current Unearned Revenue	-	-	-	-	-	0.2
Other Current Liabilities	0.22	-	-	0.5	-	0
Total Current Liabilities	4.01	3.49	3.91	3.92	35.79	2.11
Long-Term Debt	-	-	0.48	0.47	0.59	-
Long-Term Leases	-	0.16	0.54	0.09	0.09	-
Other Long-Term Liabilities	-	-	-	-	-	0.15
Total Liabilities	4.01	3.65	4.93	4.48	36.46	2.25
Common Stock	244.83	239.65	235.04	235.04	119.53	55.9
Additional Paid-In Capital	10.53	10.53	10.53	10.53	10.38	6.32
Retained Earnings	-274.1	-266.33	-251.92	-232.54	-182.14	-61.94
Comprehensive Income & Other	18.76	18.24	18	16.64	18.42	-
Total Common Equity	0.02	2.09	11.64	29.66	-33.81	0.28
Minority Interest	-	-	-	-	-0.01	-
Shareholders' Equity	0.02	2.09	11.64	29.66	-33.83	0.28
Total Liabilities & Equity	4.03	5.73	16.57	34.14	2.64	2.53
Total Debt	0.35	0.54	1.38	0.71	35.05	0.5
Net Cash (Debt)	0.87	2.44	11.75	29.66	-34.43	0.38
Net Cash Growth	-74.71%	-79.23%	-60.39%	-	-	-64.33%
Net Cash Per Share	0.00	0.01	0.06	0.37	-0.49	0.05
Filing Date Shares Outstanding	277.29	226.75	194.59	194.58	70.67	9.66
Total Common Shares Outstanding	277.29	226.75	194.59	194.58	70.67	9.57
Working Capital	-0.78	1.26	11.22	29.58	-34.04	-0.47
Book Value Per Share	0.00	0.01	0.06	0.15	-0.48	0.03
Tangible Book Value	0.02	2.09	11.64	29.66	-33.99	-0.13
Tangible Book Value Per Share	0.00	0.01	0.06	0.15	-0.48	-0.01
Machinery	1.08	0.99	1.95	1.77	1.69	1.58
Leasehold Improvements	0.32	0.31	0.29	0.28	0.28	0.24

Source: S&P Capital IQ. Standard template. Financial Sources.